Work for Avadel Pharmaceuticals plc?

Claim Your Profile

Avadel Pharmaceuticals plc Logo Image

Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc Banner Image

About Avadel Pharmaceuticals plc

201-500 Employees
Based in Dublin, Ireland

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and potential FDA approval of FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy.

NASDAQ (See More NASDAQ Companies)
Drug Manufacturers - Other (See More Drug Manufacturers - Other Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol